In this article, we discuss the 5 best 52-week low stocks to buy now. If you want to read our detailed analysis of these stocks, go directly to the 10 Best 52-Week Low Stocks to Buy Now.
5. Axsome Therapeutics, Inc. (NASDAQ: AXSM)
Number of hedge fund holders: 17
Price as of August 1, 2021: $48.59
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a New York-based biopharma company. It is placed fifth on our list of 10 best 52-week low stocks to buy now. The company’s shares have declined 31% over the course of the past year. On May 10, the firm posted earnings for the first quarter, reporting earnings per share of -$0.78, beating market predictions by $0.04. The firm has a market cap of over $1.8 billion. The short interest on the stock is more than 9%. The firm was founded in 2012.
On June 10, investment advisory Berenberg assumed coverage of Axsome Therapeutics, Inc. (NASDAQ: AXSM) stock with a Buy rating and a price target of $112. Esther Hong, an analyst at the firm, issued the ratings update.
At the end of the first quarter of 2021, 17 hedge funds in the database of Insider Monkey held stakes worth $354 million in Axsome Therapeutics, Inc. (NASDAQ: AXSM), down from 22 in the previous quarter worth $523 million.
4. Kemper Corporation (NYSE: KMPR)
Number of Hedge Fund Holders: 11
Price as of August 1, 2021: $66.01
Kemper Corporation (NYSE: KMPR) stock has declined 15% over the past twelve months. It is ranked fourth on our list of 10 best 52-week low stocks to buy now. The company is based in Illinois and markets insurance services. In earnings results for the second quarter, posted on July 29, the firm reported earnings per share of -$0.82, missing estimates by $2.19. The revenue over the period was $1.3 billion, up more than 22% compared to the revenue over the same period last year but missing predictions by $20 million.
On July 19, investment advisory Raymond James downgraded Kemper Corporation (NYSE: KMPR) stock to Market Perform from Strong Buy and reduced the price target to $80 from $90, noting that inflation could limit upside potential for the stock in the near term.
At the end of the first quarter of 2021, 11 hedge funds in the database of Insider Monkey held stakes worth $432 million in Kemper Corporation (NYSE: KMPR), down from 13 the preceding quarter worth $444 million.
In its Q2 2020 investor letter, Brown Advisory, an asset management firm, highlighted a few stocks and Kemper Corporation (NYSE: KMPR) was one of them. Here is what the fund said:
“Kemper Corporation is a diversified insurance provider with a profitable specialty segment offering nonstandard private auto insurance coverage. The company is efficiently run by a disciplined management team and trades at an attractive valuation. As a result of well-executed acquisitions and organic growth, specialty now contributes to more than two thirds’ of Kemper’s net earned premiums. It is complemented by an improving preferred property and casualty business and stable life and health insurance operation that produces consistent cash flow.”
3. Proto Labs, Inc. (NYSE: PRLB)
Number of Hedge Fund Holders: 18
Price as of August 1, 2021: $78.19
Proto Labs, Inc. (NYSE: PRLB) is placed third on our list of 10 best 52-week low stocks to buy now. The company’s shares have plunged 34% over the past twelve months. The company owns and runs an online platform that markets the development and delivery of on-demand production parts. On July 29, the firm posted earnings for the second quarter, reporting earnings per share of $0.39, missing market predictions by $0.05. The revenue over the period was $123 million, up 15% year-on-year.
On May 21, investment advisory Craig-Hallum maintained a Hold rating on Proto Labs, Inc. (NYSE: PRLB) stock and lowered the price target to $90 from $97, noting near term margin pressures and negative earnings revisions could impact the firm.
Out of the hedge funds being tracked by Insider Monkey, New York-based investment firm ARK Investment Management is a leading shareholder in Proto Labs, Inc. (NYSE: PRLB) with 3.6 million shares worth more than $444 million.
In its Q1 2021 investor letter, Harding Loevner, an asset management firm, highlighted a few stocks and Proto Labs, Inc. (NYSE: PRLB) was one of them. Here is what the fund said:
“Shares of Protolabs, a provider of 3D printing and other rapid prototyping and mold machining services for manufacturing, extended their strong performance from last year and soared early in January after the company announced its intention to acquire another on-demand digital manufacturing platform. We took advantage of their runup to sell our position.”
2. Credicorp Ltd. (NYSE: BAP)
Number of Hedge Fund Holders: 22
Price as of August 1, 2021: $100.96
Credicorp Ltd. (NYSE: BAP) stock has pulled back 20% over the past year. It is ranked second on our list of 10 best 52-week low stocks to buy now. The firm operates as a financial services firm and is based in Peru. It has a market cap of over $8 billion and posted more than $2 billion in revenue last year. Some of the finance services offered by the firm include insurance, pensions, loans, credits, deposits, and wealth management. The firm was founded in 1889 and employs over 36,000 people.
On June 9, investment advisory Citi downgraded Credicorp Ltd. (NYSE: BAP) stock to Sell from Neutral, reducing the price target to $114 from $195, noting higher short-term uncertainty around the firm and its earnings results.
At the end of the first quarter of 2021, 22 hedge funds in the database of Insider Monkey held stakes worth $236 million in Credicorp Ltd. (NYSE: BAP), up from 15 in the previous quarter worth $203 million.
1. Erie Indemnity Company (NASDAQ: ERIE)
Number of Hedge Fund Holders: 12
Price as of August 1, 2021: $184.89
Erie Indemnity Company (NASDAQ: ERIE) is ranked first on our list of 10 best 52-week low stocks to buy now. The stock has declined in value by 12% over the course of the past twelve months. The firm operates in the property and casualty insurance sector and is based in Pennsylvania. It has a market cap of over $8 billion and posted more than $2.5 billion in revenue last year. Some of the services it provides include sales, underwriting, policy issuance, and renewal services, among others, for policyholders.
In earnings results for the second quarter, posted on July 29, Erie Indemnity Company (NASDAQ: ERIE) reported earnings per share of $1.51, in line with market predictions. The revenue over the period was more than $680 million, beating estimates by close to $13 million.
At the end of the first quarter of 2021, 12 hedge funds in the database of Insider Monkey held stakes worth $616 million in Erie Indemnity Company (NASDAQ: ERIE), up from 7 in the previous quarter worth $448 million.
You can also take a peek at 10 Stocks Reddit’s WallStreetBets is Buying in July 2021 and Top Robinhood Stocks Popular on Reddit.